Fueled by an urgent need for diagnostic testing to respond to COVID-19, the in-vitro diagnostics market is experiencing explosive growth across Asia and around the globe.
The Chinese government is investing heavily in the development of new technologies that leverage AI. This includes solutions to address the COVID-19 outbreak.
A more comprehensive management approach is needed to tackle the rising threat of diabetes in the region.
Pharma and Tech Working in Sync to Enhance Health.
Foreign companies can capitalize on offering their products in Asia but must be prepared to do so at a lower price.
Trends in mHealth to be driven by increased smartphone penetration and prevalence of chronic diseases.